By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Relmada Therapeutics 



  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
Relmada Therapeutics Receives Health Canada Clearance To Commence Multiple Ascending Dose Study With Promising NMDA Receptor Antagonist 8/17/2015 6:28:11 AM
Relmada Therapeutics Announces Launch Of New Website And Corporate Communication Channels 8/12/2015 11:17:43 AM
Relmada Therapeutics Announces Reverse Stock Split In Preparation For Proposed Uplisting To NASDAQ Capital Market 8/10/2015 6:25:41 AM
Relmada Therapeutics Announces Filing Of Clinical Trial Application In Canada For Multiple Ascending Dose Study With Promising NMDA Receptor Antagonist D-Methadone 7/27/2015 11:02:53 AM
Relmada Therapeutics Appoints Charles J. Casamento To Its Board Of Directors 7/16/2015 11:49:26 AM
Enrollment In Relmada Therapeutics' Proof-Of-Concept Clinical Study For Novel Oral Formulations Of Buprenorphine Reaches Halfway Mark 6/29/2015 6:48:44 AM
BIO2015: Relmada Therapeutics To Present At 2015 BIO International Convention 6/15/2015 8:08:21 AM
Relmada Therapeutics Successfully Completes Phase 1 Single Ascending Dose Study With Promising NMDA Receptor Antagonist D-Methadone 6/10/2015 6:22:30 AM
Relmada Therapeutics To Present At The 2015 LD Micro Invitational Conference 5/27/2015 9:58:51 AM
Relmada Therapeutics To Present At The 2015 Marcum MicroCap Conference 5/19/2015 11:18:09 AM
12345
//-->